Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.
Kim, SJ; Bieganski, T; Sohn, YB; Kozlowski, K; Semënov, M; Okamoto, N; Kim, CH; Ko, AR; Ahn, GH; Choi, YL; Park, SW; Ki, CS; Kim, OH; Nishimura, G; Unger, S; Superti-Furga, A; Jin, DK
Human genetics, 129(5):497-502, 2011
Sclerosteosis and Van Buchem disease are related recessive sclerosing bone dysplasias caused by alterations in the SOST gene. We tested the hypothesis that craniodiaphyseal dysplasia (CDD) (MIM 122860), an extremely rare sclerosing bone dysplasia resulting facial distortion referred to as "leontiasis ossea", could also be caused by SOST mutations. We discovered mutations c.61G>A (Val21Met) and c.61G>T (Val21Leu) two children with CDD. As these mutations are located in the secretion signal of the SOST gene, we tested their effect on secretion by transfecting the mutant constructs into 293E cells. Intriguingly, these mutations greatly reduced the secretion of SOST. We conclude that CDD, the most severe form of sclerotic bone disease, is part of a spectrum of disease caused by mutations in SOST. Unlike the other SOST-related conditions, sclerosteosis and Van Buchem disease that are inherited as recessive traits seem to be caused by a dominant negative mechanism.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :2,767,856
Total Download :1,129,553
Today View :1,248
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.